88 related articles for article (PubMed ID: 23286403)
1. [Clinical characteristics and prognostic factors of malignancy-associated hypercalcemia in squamous cell carcinoma].
Zhang SJ; Hu Y; Jiao SC; Liu ZF; Tao HT
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):585-9. PubMed ID: 23286403
[TBL] [Abstract][Full Text] [Related]
2. Analysis on survival and prognostic factors for cancer patients with malignancy-associated hypercalcemia.
Zhang SJ; Hu Y; Cao J; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6715-9. PubMed ID: 24377594
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated hypercalcaemia in squamous-cell malignancies: a survival and prognostic factor analysis.
Le Tinier F; Vanhuyse M; Penel N; Dewas S; El-Bedoui S; Adenis A
Int J Oral Maxillofac Surg; 2011 Sep; 40(9):938-42. PubMed ID: 21489752
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemic complication in patients with oral squamous cell carcinoma.
Iwase M; Takemi T; Manabe M; Nagumo M
Int J Oral Maxillofac Surg; 2003 Apr; 32(2):174-80. PubMed ID: 12729778
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia in patients with esophageal cancer.
Geddes LG; Dorn RA; Wadleigh RG
J Exp Clin Cancer Res; 1999 Mar; 18(1):61-2. PubMed ID: 10374679
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma.
Takai E; Yano T; Iguchi H; Fukuyama Y; Yokoyama H; Asoh H; Ichinose Y
Cancer; 1996 Oct; 78(7):1384-7. PubMed ID: 8839542
[TBL] [Abstract][Full Text] [Related]
7. Clinical analysis of 64 patients with lung-cancer-associated hypercalcemia.
Li X; Bie Z; Zhang Z; Li Y; Hu X; Liu W; Zhang S; Cheng G; Ai B
J Cancer Res Ther; 2015 Nov; 11 Suppl():C275-9. PubMed ID: 26612452
[TBL] [Abstract][Full Text] [Related]
8. [Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue].
Yang AK; Liu TR; Chen FJ; Ma XF; Guo ZM; Song M; Li QL; Zeng ZY
Ai Zheng; 2008 Dec; 27(12):1315-20. PubMed ID: 19080001
[TBL] [Abstract][Full Text] [Related]
9. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases.
Ling W; Mijiti A; Moming A
J Oral Maxillofac Surg; 2013 Apr; 71(4):775-85. PubMed ID: 23265849
[TBL] [Abstract][Full Text] [Related]
10. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.
Mabuchi S; Okazawa M; Matsuo K; Kawano M; Suzuki O; Miyatake T; Enomoto T; Kamiura S; Ogawa K; Kimura T
Gynecol Oncol; 2012 Oct; 127(1):114-20. PubMed ID: 22728518
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia in advanced head and neck squamous cell carcinoma: prevalence and potential impact on palliative care.
Alsirafy SA; Sroor MY; Al-Shahri MZ
J Support Oncol; 2009; 7(5):154-7. PubMed ID: 19831158
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis.
Penel N; Dewas S; Doutrelant P; Clisant S; Yazdanpanah Y; Adenis A
Support Care Cancer; 2008 Apr; 16(4):387-92. PubMed ID: 17710443
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment and prognosis of thymic squamous cell carcinoma: a retrospective analysis of 105 cases.
Zhao Y; Zhao H; Hu D; Fan L; Shi J; Fang W
Ann Thorac Surg; 2013 Sep; 96(3):1019-24. PubMed ID: 23866799
[TBL] [Abstract][Full Text] [Related]
15. [Hypercalcemia and squamous cell carcinoma of the upper respiratory-digestive tracts. Incidence and prognosis].
Degardin M; Nguyen M; Beaurin D; Lesoin A; Fournier C; Lefebvre JL; Cappelaere P
Bull Cancer; 1995 Nov; 82(11):975-80. PubMed ID: 8535025
[TBL] [Abstract][Full Text] [Related]
16. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.
Youssef R; Kapur P; Shariat SF; Arendt T; Kabbani W; Mosbah A; Abol-Enein H; Ghoneim M; Lotan Y
BJU Int; 2012 Oct; 110(7):961-6. PubMed ID: 22372762
[TBL] [Abstract][Full Text] [Related]
18. [Prognosis and treatment for 98 patients with carcinoma of nasal cavity].
Hu WH; Xie FY; Chen DZ; Wu Y; Jiao JJ; Peng WJ; Yan C; Fang SH
Ai Zheng; 2004 Nov; 23(11 Suppl):1542-5. PubMed ID: 15566676
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
Castro MA; Dedivitis RA; Ribeiro KC
ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
[TBL] [Abstract][Full Text] [Related]
20. Humoral hypercalcemia of malignancy in squamous cell carcinoma of the skin: parathyroid hormone--related protein as a cause.
Cisneros G; Lara LF; Crock R; Whittier FC
South Med J; 2001 Mar; 94(3):329-31. PubMed ID: 11284521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
